Our expertise extensively represents the fields of health economics, medicine, and natural sciences. Our experience has been gathered in different positions in the pharmaceutical industry, and healthcare, research, and academic institutions. Our wide-ranging experience and diversified expertise constitute our absolute strengths in serving our customers in the pharmaceutical and health technology fields and the healthcare sector.
Learn more about our experts by reading their profiles below and do not hesitate to contact us.
Jaana established Medaffcon in 2009. Prior to that, she worked in expert and management positions in the pharmaceutical industry for almost ten years. Jaana has also worked as a hospital doctor and is a specialist in surgery. In 1999, she defended her doctoral thesis on health policy related to customer payments in healthcare.
Jaana’s most essential contribution to Medaffcon’s team is her wide-ranging experience and expertise. Jaana is particularly interested in the future development of the Finnish healthcare sector. In particular, the use of knowledge in decision-making and new opportunities brought by digitalization fascinates Jaana. “I am especially looking forward to how we can improve personalized treatment options in healthcare and systematically evaluate the effectiveness and cost-effectiveness of treatments”.
Jarmo joined Medaffcon as a partner and CEO in 2010, having previously worked in various expert and management positions in pharma companies for eight years. Jarmo has a degree in economics and before entering the pharmaceutical industry, he held an office at the Turku School of Economics and also worked as a research fellow at Turku University Hospital.
Jarmo has strong expertise in new health technology innovations and how the demands and expectations of authorities, markets and customers are matched. He also brings to Medaffcon extensive experience in health economics and its applications in research and commercialization, as well as a broad understanding of the ever-changing operating environment.
“From an access point of view, the Finnish health technology market is constantly becoming more demanding and therefore also more attractive from my point of view. On the other hand, increasing demands to demonstrate the effectiveness and cost-effectiveness of healthcare are broadening the scope and opportunities for Medaffcon to be involved in the development of healthcare as a whole”.
Tatu’s doctoral dissertation, defended in 1999, focused on gallstone disease and cholesterol metabolism. Since then, he has worked in the pharmaceutical industry in different therapeutic areas, mainly as a Scientific or Medical Advisor, aiming to produce medical added value of high quality, benefiting all interest groups. Tatu has worked in the pharmaceutical industry or its interface for almost 20 years, in expert positions related to clinical research, drug development and Medical Affairs. He has experience in both national and international clinical trials, working as a Medical Researcher as well as in designing studies and in drafting protocols.
Tatu joined Medaffcon as a Partner in 2010. His background enables effective analyses and solution processes of challenges in the field. Tatu is particularly interested in the development of drug preforms from early-stage studies towards the markets. His interest for the bases at a molecular level and signal transmission routes is stunning. Tatu enjoys teaching and can explain even complex issues in a simple and understandable manner.
Liisa joined Medaffcon in January 2020. She has over ten years of experience of working as a scientific advisor and research scientist for private and public sector organizations. Liisa holds a PhD in medical genetics, and she mentions that especially the therapeutic areas related neurology and psychiatry appeal to her.
Liisa’s strengths include strong expertise on medical sciences and research, as well as on creating evidence-based content, because she also has experience of being a science book author. Establishing cross-scientific collaboration, scientific exchange, and creating networks are one of her key work philosophies.
One of her main professional interests is the secondary use of health-related data to create real-world-evidence in order to improve and develop treatment practices. ”Due to the unique registries and data lakes available in Finland, in principle all the required data is already available or accumulating all the time, which makes it important to utilize this real-world-data to improve patient care and general well-being.”
Päivikki joined Medaffcon’s team in September 2017. She has a PhD in cancer biology. Päivikki worked for the first 10 years of her career as a cancer researcher. Following her career in research, Päivikki has worked in different specialist positions in sales, research, quality and registration fields in pharmaceutical, medical device and CRO companies. Before joining Medaffcon, Päivikki worked in the Finnish Clinical Biobank Tampere, where she was responsible for the construction and development of the biobank’s quality system and operational processes.
Päivikki works as a scientific advisor in Medaffcon, where her extensive experience as a project leader, combined with strong scientific expertise, can be utilized in various client projects. Päivikki is fascinated by the continuous development of the healthcare industry as a result of cooperation between different actors. “It’s really interesting to see how the utilization of real-world data is evolving due to the possibility to access new data sources and due to changes in legislation”.
Sanna joined Medaffcon’s team in November 2019. In her PhD, she studied the potential of high-intensity interval training (HIIT) in the prevention and management of type 2 diabetes. After defending her PhD in 2018, she worked as a post-doctoral researcher at the University of Turku. In addition, Sanna has experience working as an entrepreneur in the field of work-wellbeing. As a base-education, she has two master’s degrees (Biomedicine and Exercise Physiology).
Sanna’s strengths include strong expertise in science, diverse educational background, excellent management skills and above all, her positive nature. She is fascinated by the dynamics and endless innovative opportunities in the healthcare industry. “It is extremely interesting to see how individual treatment paths can be tailored in the future for example based on the genome or different biomarkers. In addition, new digital solutions in the prevention and management of different diseases will surely improve health and the daily lives of many individuals”.
Heini joined Medaffcon’s Market Access team in May 2018. She has graduated in Health Economics from the University of Eastern Finland, and her master’s thesis discusses risk-sharing agreements in the pharmaceutical market.
Heini is interested in the changes occurring in the pharmaceutical and healthcare industries as well as in the possibilities of Health Economics in assessing the methods and economic resources in the field. Heini’s assets include her state-of-the-art theoretical knowledge in the field of Health Economics, combined with practice- and patient-oriented thinking.
Krista joined Medaffcon in May 2017 as a Scientific Project Manager. Krista has worked in the pharmaceutical industry in both sales and scientific services. She has gained experience in pain management and diabetes therapeutic areas.
In the field, Krista is interested in constant development, changing lines of action and innovations. Moreover, she is interested in developing transparent and ethical cooperation between physicians and the pharmaceutical industry.
Krista holds a degree in Biomedicine and has gained extensive experience in working at the customer interface. Krista’s strengths include her solid presentation and human relations skills as well as her determination.
Lotta joined Medaffcon in spring 2017. She holds a master’s degree in Health Sciences, with Health Economics as her major. In her master`s thesis, Lotta analyzed how real-world data can be utilized in the assessment of drug costs. Lotta worked at Orion during her studies.
Lotta brings to Medaffcon`s team her expertise in Health Economics that she applies in health technology assessments and price and reimbursement processes.
In the field, Lotta`s special interests are working for the benefit of patients and how health economic information is utilized in health care decision making. “I believe that knowledge of health economics and the need for health economic information will play an increasingly important role in future health care”.
Mariann joined Medaffcon’s team in 2016 after finishing her PhD. The transition to real world evidence (RWE) research was a natural continuum to her previous research career. Through RWE studies, she has had the privilege to gain a broad insight into working with different stakeholders within the healthcare field. The vast proportion of her days goes towards interacting with clients, planning and performing RWE studies, and supporting Medaffcon’s RWE team. Subjects that keep her work interesting are the vast variability of customers and projects, problem-solving, and interacting with people.
“The number of RWE studies has increased since stakeholders within the healthcare industry have an increasing demand for knowledge-based decision making tools that need to be fulfilled. The future, therefore, has an ever-increasing emphasis on RWE”.
Triin joined Medaffcon´s health economic team in April 2015. Triin´s main field of responsibilities are health economic and pharmaceuticals market access related projects, for example, health economic evaluations and price and reimbursement applications. During her consultant career at Medaffcon, Triin has also been an in-house consultant for one pharma company in the role of Market Access Manager for almost two years.
Triin has a Master of Science degree, majoring in Health Economics, and a degree as a registered nurse. Triin has previous work experience from the pharmaceutical industry in the Market Access function and from an operating theatre in the public sector.
“It´s great to be involved in the constantly developing field of health care and market access, such as conditional reimbursement, risk-sharing agreements at hospitals, and HTAs, to mention just a few examples. The best thing about my job is to promote the use of cost-effective health care technologies”.
Tanja joined Medaffcon’s team in November 2016. Before that, she worked as a researcher at the National Institute for Health and Welfare. Tanja has also worked in an international research group, as a course instructor as well as in financial administration and customer service. She holds MSc degrees in both Health Economics and in the field of Economics and Business Administration.
Tanja’s strengths include her educational and occupational background in health economics from Finland and abroad. Tanja has a special interest in utilizing real-world evidence data to be used in evaluations. “By utilizing data resources to support decision-making we become more aware of how scarce resources should be allocated”.
Lasse started at Medaffcon in November 2014 as a Scientific Project Manager. He has worked in the pharmaceutical industry since 2001 in different positions: 6 years in sales (medicinal products for prostatic cancer and erectile disorder, antimicrobial, painkiller, anti-obesity agent), 3 years in development/project work (obesity treatment), 5.5 years as a Scientific Expert (urology, nephrology, anaesthesiology) and as the substitute for a liable director. Lasse has a Master of Science degree (Pharmacy), and since 2014, he has been a Doctoral Student at the University of Tampere (in a hemodynamic research group).
In the field, Lasse is particularly interested in the constantly changing operational environment and different interest groups and the individualized acknowledgement of their needs, the significance of the cost benefit-effectiveness analysis of medicinal products in healthcare decision-making, as well as working with significant scientific data.
Lasse’s strengths include his wide-ranging experience in the pharmaceutical industry, covering different therapeutic and operational areas, and in Cross-functional team work in a matrix organization.
Sr. Scientific Project Manager Medical Affairs Lead
Sr. Scientific Project Manager Medical Affairs Lead
M.Sc. (Food Science), MBA
Kristiina joined Medaffcon as a Business development manager in 2012. She started her career in a CRO, after which she worked in scientific advisor and line manager positions in two large pharmaceutical organizations, now reaching already 15 years in the business. Kristiina holds master’s degrees in both Nature Sciences and Business (Henley MBA).
At Medaffcon, nowadays as a Medical Affairs team lead, Kristiina leverages her long experience from various stakeholders in the business and her vast therapeutic area expertise in close collaboration with her team to the benefit of customer assignments. When asking what the best part of this work is, she refers to the fast change and the continuous strive for the better, for all of us, as health care service utilizers. ”Every year, I feel that never before have we been working on such vast and important topics and yet, next year the feeling is the same again”.
Sr. Health Economist Access & HE Lead
Sr. Health Economist Access & HE Lead
M.Sc. (Economics & Health Economics)
Tatu joined Medaffcon in the fall of 2016. Tatu holds two master’s degrees, majoring in Marketing and Health Economics. Before joining Medaffcon, he worked in the pharmaceutical industry at Boehringer Ingelheim as an Account Manager. At Medaffcon, Tatu works mainly with health technology assessments and is the access & health economics team lead. Through his educational and professional background, Tatu has a wide range of expertise in the pharmaceutical industry and understands the needs of each function.
Tatu’s strength is his comprehensive understanding of the pharmaceutical industry and healthcare environment. Tatu is particularly interested in the possibility to turn data into understandable information to support healthcare decision-making.
“I love the hype around the utilization of real-world effectiveness and cost-effectiveness data. Now we need steps to include the data as a systematic part of the decision-making process, which allows the optimal allocation of resources”.
Kalle Snicker joined Medaffcon’s team in September 2017. He has a long history in the pharmaceutical industry. Over the years, he has gained experience in leading positions in sales and marketing, running the Baltic business unit, and in recent years, leading the oncology market access functions at Novartis Finland.
At Medaffcon, Kalle has been developing the introduction of hospital medicines, together with various pharmaceutical companies and authorities. In recent years, there has been a significant development in the introduction of hospital medicines, with the focus on the evaluation of medicines. The development and implementation of such evaluation are one of Kalle’s strongest competencies, which can benefit any actor in the industry.
Kalle’s strengths include his extensive and comprehensive view on how the industry functions as well as his ability to predict how future challenges can be considered and how the best possible result for the patient can be achieved in a new operational environment.
Milla started at Medaffcon in February 2019. Milla obtained her PhD in cell biology from Utrecht University in the Netherlands. From 2014 until 2019 she worked as a postdoctoral researcher at the Laboratory of Neurobiology at the University of Helsinki.
Milla’s strengths include a solid scientific background, excellent organizational skills, and a diverse and international educational background. Milla is especially interested in working with clinically relevant scientific data, in the possibilities of precision medicine, and in collaborating with the different stakeholders of the health care sector. “I believe that the importance of real-world evidence studies will increase, and the research results can be used to improve individual treatment paths in the future.”
Ritva joined Medaffcon’s team in March 2018. Before this, she had worked for almost six years at Farenta in corresponding tasks, providing pharmaceutical companies with strategic consultation and expert assistance related to Market Access functions. In addition, Ritva holds more than 20 years of experience in the pharmaceutical industry, where she has worked as a Market Access Manager at Sanofi (12 years), as a Regulatory Affairs Manager at Bayer and as a Researcher in Pharmaceutical Product Development at Orion.
In the pharmaceutical industry, Ritva is interested in Market Access issues particularly due to their diversity and societal impact. “Market Access is a great observational spot to view the development of new innovative medicinal treatment, aiming to improve patients’ treatment in its entirety. I consider it important to increase cooperation between different actors in the pharmaceutical industry and to find such new solution models that make effective treatment optimally available for patients without raising society’s costs unreasonably“.
Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.
Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.
“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.
Samuli joined Medaffcon in November 2018. He acquired a master’s degree in Statistics at the University of Helsinki, specializing in Bioinformatics in September 2018. Before joining Medaffcon, Samuli had two years’ worth of experience in research as a research assistant at the University of Helsinki, where he contributed to unraveling the genetic and epigenetic background of psychological characteristics (Depsy-group).
Samuli is especially interested in producing influential research data based on information on real-world patients. He is also interested in applying varying statistical and machine learning methods. Samuli has a broad theoretical and methodological understanding, as well as experience in working with big data. He is a problem solver and has an analytical take on work.
“I see that the health sector is being transformed by digitalization. I am excited to further develop the new opportunities made possible by the automated collection of patient data”.
Werneri joined Medaffcon’s Medical team as a trainee in November 2017. He has a Bachelor of Science degree in Biomedicine. In addition to his work, Werneri is currently undertaking two different master’s degrees: in Biomedicine and Wellness Technology. As a young employee, Werneri brings fresh perspectives from his university studies and applies these to his practical work. In the field, he is interested in constantly changing circumstances, multi-professional working environment, and the possibilities digitalization offers when improving health.
Kristiina joined Medaffcon’s RWE team in the fall of 2019. She holds a PhD and her doctoral dissertation concentrated on cell biology of a rare neurological disease. After defending her PhD, Kristiina worked on projects using iPS cell technology in several different research groups for rare diseases. In addition, she has experience in the most common diseases, as she has worked with diabetic research, for example.
“In this work, we can see from the field how know-how is effectively acquired and for what purposes it is used in healthcare. I look forward to seeing the full potential of biobank sample collections for future use in RWE research, including rare diseases”.
Tomi Vahevaara started working at Medaffcon in January 2017 as a Sales Director. He has been working in the pharmaceutical industry for over 35 years. Therefore, he has gained wide-ranging experience in international expert and managerial positions within the innovative pharmaceutical industry. Before joining Medaffcon, Tomi worked for ten years as the Managing Director of Eli Lilly for Finland, the Baltic States, and Poland.
Tomi has solid and wide-ranging expertise in different positions in the pharmaceutical field and is well connected in the entire health industry network. He serves as the Chairman of the Board of the Finnish Mutual Insurance Company for Pharmaceutical Injury Indemnities and as a Board Member in the Finnish Co-operative for Pharmaceutical Injury Indemnities. Tomi is particularly interested in the significant economic and investment opportunities for Finland and those companies working in the Finnish health industry.
Tuuli joined Medaffcon in May 2012 as an Assistant. She completed her Bachelor of Business Administration (International Business) degree in May 2015, after drafting her Bachelor’s Thesis for Medaffcon on the internationalisation practices of expert organisations. After graduation, Tuuli’s job description at Medaffcon has included, inter alia, financial administration and marketing tasks.
Since December 2015, Tuuli has worked as Marketing Lead, managing Medaffcon’s 2 websites and social media presence, designing and implementing marketing activities and online content, and organizing Medaffcon’s events.
Maria Rjazanova joined Medaffcon as a financial assistant in August 2018. Currently, she is studying a Multilingual Management Assistant bachelor’s degree at Haaga-Helia, majoring in Financial Management.
In the field, Maria is interested in individualized drug therapy, new innovations brought by digitalization and which opportunities these bring to the development of human well-being.